This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Big Bus says NY AG findings on consumer harm in monopoly suit 'demonstrably false'

( April 17, 2025, 16:26 GMT | Official Statement) -- MLex Summary: Big Bus said a recent press release by the New York Attorney General, as part of a monopoly suit alleging the company conspired to pressure major tour attractions to refuse to enter into trade partner agreements with Go New York, is "irresponsible." In a statement, Big Bus said the press release is also "rife with mischaracterizations, inaccuracies" and is unsupported by facts. "Big Bus agreed to resolve the AG’s investigation only to avoid the further needless diversion of resources and business attention — allowing it to instead focus on its core mission: providing world-class tourism experiences for its customers," the statement said. Big Bus said it categorically rejects the "so-called findings" including those concerning potential harm to customers and competition, which are "demonstrably false."Full statement follows....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections